Metformin (generic), Glucophage Newswire (Page 7)

Metformin (generic), Glucophage Newswire (Page 7)

Comprehensive Real-Time News Feed for Metformin (generic), Glucophage. (Page 7)

Results 121 - 140 of 1,867 in Metformin (generic), Glucophage

  1. Eat broccoli to keep diabetes in checkRead the original story w/Photo

    Jun 16, 2017 | Newkerala.com

    Washington D.C. [U.S.A.], June 17 : Here's another reason to consume broccoli, as researchers have identified a new anti-diabetic substance, richly occurring in broccoli, which can significantly lower the blood sugar levels. The findings indicated that blood sugar of the animals that received sulforaphane dropped by 23 percent in four weeks.

    Comment?

  2. Viral Photo Shows Firefighters Holding Children Involved In Car CrashRead the original story w/Photo

    Jun 16, 2017 | KRMG-AM Tulsa

    For a second straight day, President Donald Trump took to Twitter to vent his frustration at the investigation of Russian interference in the 2016 elections, as he publicly said that he was "being investigated" for firing FBI Director James Comey last month, appearing to confirm news reports that he is facing a possible probe dealing with obstruction of justice. "I am being investigated for firing the FBI Director by the man who told me to fire the FBI Director!" Trump said on Twitter, appearing to refer to Deputy Attorney General Rod Rosenstein.

    Comment?

  3. FDA posts briefing materials prior to Advisory Committee meeting for Victoza label updateRead the original story

    Jun 16, 2017 | GlobeNewswire

    BagsvA rd, Denmark, 16 June 2017 - Novo Nordisk today announced that the US Food and Drug Administration has published the briefing documents ahead of the Advisory Committee meeting to discuss the supplemental New Drug Application for approval of VictozaA injection to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes mellitus and high cardiovascular risk, given as an adjunct to standard treatment of cardiovascular risk factors. The meeting takes place on 20 June 2017.

    Comment?

  4. Broccoli may help type 2 diabetes patients manage their blood sugar, study findsRead the original story w/Photo

    Jun 16, 2017 | Medical News

    "There are strong indications that this can become a valuable supplement to existing medication," said Anders Rosengren, Docent in Metabolic Physiology at the University of Gothenburg and affiliated with the Lund University Diabetes Centre. The study findings published in Science Translational Medicine could offer a much needed alternative to address the condition, which has become a worldwide epidemic.

    Comment?

  5. Study: Broccoli extract lowers blood sugar for type 2 diabetes...Read the original story w/Photo

    Jun 16, 2017 | WFTV Orlando

    A powder containing a chemical found in broccoli sprouts is capable of lowering blood sugar levels of persons with type 2 diabetes, according to a study published Wednesday by Science Transitional Medicine . The powder contains a highly concentrated dose of sulforaphane, according to study co-author Anders Rosengren of the University of Gothenburg in Sweden.

    Comment?

  6. Step up fight against diabetesJun. 12, 2017, 7:8 PM AstRead the original story

    Jun 12, 2017 | Trinadad Express

    May I suggest that our nation tackle the issue of diabetes head on? I hope the Minister of Health and the Minister of Finance both read this letter. This is a matter of money.

    Comment?

  7. New diabetes pill costs just A 1.30 a dayRead the original story w/Photo

    Jun 12, 2017 | Daily Mail

    Pill for diabetes that costs just A 1.30 a day also cuts the risk of heart and kidney disease by 14% Experts last night said the study, carried out among 10,000 patients in 30 countries, heralds a 'new era' in the treatment of type two diabetes. Canagliflozin, a pill taken once a day before breakfast, is designed to lower blood sugar levels and keep weight down.

    Comment?

  8. Can folks with type 2 diabetes forgo the finger stick?Read the original story w/Photo

    Jun 12, 2017 | KNDU

    People with type 2 diabetes who aren't taking insulin don't necessarily need to check their blood sugar levels, a new study contends. Many of these patients use "finger prick" blood sugar monitors, but "testing blood sugar didn't have any impact on their blood sugar," said study author Dr. Laura Young, an assistant professor of medicine at the University of North Carolina.

    Comment?

  9. Cheap drug 'could cut heart disease risk among diabetics'Read the original story w/Photo

    Jun 12, 2017 | This Is London

    A cheap new drug could cut the risk of heart disease for people with diabetes, according to a new worldwide scientific study. Researchers based in Scotland found a drug called metformin could help improve the cardiovascular and metabolic health of adults with longstanding type 1 diabetes.

    Comment?

  10. Drug lowers levels of biomarker linked to ALSRead the original story

    Jun 12, 2017 | Science Daily

    A new study finds that a decades-old drug used to treat malaria lowers levels of a biomarker linked to the inherited form of ALS. A new study finds that a decades-old drug used to treat malaria lowers levels of a biomarker linked to the inherited form of amyotrophic lateral sclerosis, also known as ALS and Lou Gehrig's Disease.

    Comment?

  11. Is the Finger-Stick Blood Test Necessary for Type 2 Diabetes Treatment?Read the original story

    Jun 12, 2017 | Health News Digest

    Chapel Hill, NC - In a landmark study, UNC School of Medicine researchers have shown that blood glucose testing does not offer a significant advantage in blood sugar control or quality of life for type 2 diabetes patients who are not treated with insulin. The paper, published in JAMA Internal Medicine , details findings from a randomized trial called "The MONITOR Trial."

    Comment?

  12. Long-Term Metformin Drops Risk of Heart Disease in Adults with T1D?Read the original story w/Photo

    Jun 12, 2017 | Pharmacy Times

    Treatment with metformin may help to reduce long-term heart disease risk in middle-aged adults with type 1 diabetes who are at increased risk for cardiovascular disease , according to a study presented simultaneously this week at the American Diabetes Association's 77th Scientific Sessions at the San Diego Convention Center and in T A multicenter, international clinical trial, the REMOVAL trial, enrolled patients at 23 centers across the United Kingdom, Australia, Canada, Denmark and the Netherlands and used ultrasound to measure atherosclerosis in the carotid arteries as a surrogate marker of heart disease.

    Comment?

  13. Phase 3 Results Show Lower A1C for Ertugliflozin, Combined With Metformin and With SitagliptinRead the original story w/Photo

    Jun 12, 2017 | The American Journal of Managed Care

    Results presented at the 77th Scientific Sessions of the American Diabetes Association are for combinations with ertugliflozin, an investigational SGLT2 inhibitor before FDA. Ertugliflozin, the investigational SGLT2 inhibitor under development by Merck and Pfizer, achieved significant reductions in glycated hemoglobin in studies unveiled Saturday that examined the type 2 diabetes therapy in combination metformin and with sitagliptin, the top-selling dipeptidyl peptidase-4 inhibitor sold as Januvia.

    Comment?

  14. vTv Therapeutics Presents Data Highlighting Further Potential Of...Read the original story

    Jun 11, 2017 | BioSpace

    In a poster presentation titled, "Is Less More? Learning to dose the oral, non-peptide GLP-1R Agonist, TTP273 in Type 2 Diabetics," researchers from vTv reviewed results from a concentration/effect analysis on the LOGRA study showing that lower doses of TTP273 may show more pronounced effects for key efficacy endpoints, including a reduction in HbA1c, weight and fasting plasma glucose. The characteristics of TTP273 provide a potential scientific rationale supporting the concept that for TTP273, less may be more.

    Comment?

  15. American Diabetes Association Release: Long-Term Metformin Treatment...Read the original story

    Jun 11, 2017 | BioSpace

    It is also widely used to improve cardiovascular risk in adults with type 2 diabetes. This study examined if similar benefits could be expected for people with type 1 diabetes.

    Comment?

  16. An inexpensive first-line treatment for type 2 diabetes may also...Read the original story w/Photo

    Jun 12, 2017 | PhysOrg Weblog

    An inexpensive first-line treatment for type 2 diabetes may also reduce heart disease in those with type 1 diabetes, according to a new global trial led by the University of Glasgow. The REMOVAL trial's results, announced today at the American Diabetes Association's 77th Scientific Sessions conference in San Diego, and published in the journal The Lancet Diabetes and Endocrinology , shows how the drug metformin has potentially beneficial effects on cardiovascular and metabolic outcomes in adults with longstanding type 1 diabetes .

    Comment?

  17. Finger-stick blood test may not help diabetes patients who do not use insulin, study showsRead the original story w/Photo

    Jun 11, 2017 | Medical News

    In a landmark study, UNC School of Medicine researchers have shown that blood glucose testing does not offer a significant advantage in blood sugar control or quality of life for type 2 diabetes patients who are not treated with insulin. The paper, published in JAMA Internal Medicine , details findings from a randomized trial called "The MONITOR Trial."

    Comment?

  18. Potential for combination of dipeptidyl peptidase-4 inhibitors and...Read the original story

    Jun 11, 2017 | CiteULike

    Potential for combination of dipeptidyl peptidase-4 inhibitors and sodium-glucose co-transporter-2 inhibitors for the treatment of type 2 diabetes. In individuals with advanced type 2 diabetes , combination therapy is often unavoidable to maintain glycaemic control.

    Comment?

  19. Prolonged Ketosis in a Patient With Euglycemic Diabetic Ketoacidosis Secondary to Dapagliflozin.Read the original story

    Jun 11, 2017 | CiteULike

    Since the approval of sodium-glucose cotransporter 2 inhibitors by the US Food and Drug Administration for type 2 diabetes, there have been several reports of euglycemic diabetic ketoacidosis in patients using this class of medication. We present a case of euglycemic diabetic ketoacidosis where ketonemia and glucosuria persisted well beyond the expected effect of dapagliflozin.

    Comment?

  20. Israeli researchers find diabetes drug may ward off breast cancerRead the original story w/Photo

    Jun 11, 2017 | Jerusalem Post

    A drug commonly used to treat type-2 diabetes can prevent or delay the recurrence of some types of breast cancer, researchers at Hadassah-University Medical Center have found. Metformin was found in a study of 8,000 patients around the world to reduce the risk of repeated HER2-positive breast cancers.

    Comment?